Genetic research
Enhancing CAR-gd T Cell Therapies for Improved Anti-Tumor Potency
Gene therapy researchers at Miltenyi Biotec GmbH have made significant advancements in optimizing CAR-gd T cell therapies for enhanced anti-tumor potency. The team, led by Lorraine Pinot and including Aylin Saßor, Nina Moker, Congcong Zhang, Els Verhoeyen, Jose Villacorta Hidalgo, and Rimas J. Orentas, employed a Baboon-pseudotyped lentiviral vector (BaEV-LV)